These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 18210840

  • 1. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K.
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [Abstract] [Full Text] [Related]

  • 2. [ALS and microglia--a player for non-cell-autonomous neuron death].
    Yamanaka K, Yamashita H.
    Brain Nerve; 2007 Oct; 59(10):1163-70. PubMed ID: 17969357
    [Abstract] [Full Text] [Related]

  • 3. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ, Talbot K.
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [Abstract] [Full Text] [Related]

  • 4. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM, Morrison JH, Gordon JW.
    J Exp Zool; 2008 May; 282(1-2):32-47. PubMed ID: 9723164
    [Abstract] [Full Text] [Related]

  • 5. Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).
    Julien JP, Millecamps S, Kriz J.
    Novartis Found Symp; 2005 May; 264():183-92; discussion 192-6, 227-30. PubMed ID: 15773754
    [Abstract] [Full Text] [Related]

  • 6. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
    Tanaka K, Okada Y, Kanno T, Otomo A, Yanagisawa Y, Shouguchi-Miyata J, Suga E, Kohiki E, Onoe K, Osuga H, Aoki M, Hadano S, Itoyama Y, Ikeda JE.
    Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
    Zhang J, Ito H, Wate R, Ohnishi S, Nakano S, Kusaka H.
    Acta Neuropathol; 2006 Dec; 112(6):673-80. PubMed ID: 16957927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M, Savasta M, Besson G.
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis?
    Almer G, Kikuchi H, Teismann P, Przedborski S.
    Ann Neurol; 2006 Jun; 59(6):980-3. PubMed ID: 16619237
    [Abstract] [Full Text] [Related]

  • 20. [ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor].
    Funakoshi H, Ohya W, Kadoyama K, Nakamura T.
    Brain Nerve; 2007 Oct; 59(10):1195-202. PubMed ID: 17969361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.